Abstract
Further attempts to achieve a clinical distinction between hypertrophic and keloid scars seem pointless. Research in recent years has shifted from the extracellular components towards the cells themselves. Much more work needs to be done to characterise the activities of the various cell lines and the mechanisms of their control. A key question is whether the cells are due to a different subpopulation of fibroblasts or whether they are normal wound-healing cells acting under some chemical or physical influence. Ultimately, most hypertrophic and keloid scars become flat and pale, although the time sequence is very variable and there is little understanding of the process of scar maturation. Meanwhile, the problem remains as a significant cause of human suffering deserving further investment of time and resources.
Similar content being viewed by others
Article PDF
References
Alibert JLM . Description des maladies de la peau observées a l'hospital Saint-Louis et exposition des meilleurs méthodes suivés pour leur traitement. Paris: Barrois l'Aine et Fils, 1806.
Alibert JLM . Note sur la keloide. J Univ Sci Med 1816; 2: 207.
Alibert JLM . Quelques recherches sur la cheloide en mémoires de la société d'emulation. Paris: Migneret, Crochard et Gabon, 1817.
Linares HA, Larson DL, Willis-Galstaun BA . Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns 1993; 19(1): 17–21.
Rockwell WB, Cohen IK, Ehrlich HP . Keloids and hypertrophic scars: a comprehensive review. Plastic Reconstructive Surg 1989; 84: 827–37.
Brody GS . Keloids and hypertrophic scars [letter]. Plastic Reconstructive Surg 1990; 86: 804.
Norris JE . Hypertrophic scar and keloid [letter]. Plastic Reconstructive Surg 1991; 88: 372–3.
Meyer M, McGrouther DA . A study relating wound tension to scar morphology in the pre-sternal scar using Langer's technique. Br J Plastic Surg 1991; 44: 291–4.
Langer K . On the anatomy and physiology of the skin. Translation by T Gibson. Br J Plastic Surg 1978; 31: 3–8, 93-106, 185-99, 273-8.
Placik OJ, Lewis VL . Immunologic associations of keloids. Surg Gynecol Obstet 1992; 175: 185–93.
Myles ME, Russell JD, Trupin JS, Smith JC, Russell SB . Keloid fibroblasts are refractory to inhibition of DNA synthesis by phorbol esters: altered response is accompanied by reduced sensitivity to prostaglandin E2 and altered down-regulation of phorbol ester binding sites. J Biol Chem 1992; 267: 9014–20.
Sit KH, Lau YK, Aw SE . Differential oxygen sensitivities in G6PDH activities of cultured keloid and normal skin dermis single cells. J Dermatol 1991; 18: 572–9.
Lee KS, Song JY, Suh MH . Collagen mRNA expression detected by in situ hybridisation in keloid tissue. J Dermatol Sci 1991; 2: 316–23.
Sollberg S, Peltonen J, Uitto J . Combined use of in situ hybridisation and unlabelled antibody peroxidase anti-peroxidase methods: simultaneous detection of type I procollagen mRNAs and factor VIII-related antigen epitopes in keloid tissue. Lab Invest 1991; 64: 125–9.
Parkhouse N, Crowe R, McGrouther DA, Burnstock G . Painful hypertrophic scarring and neuropeptides [letter]. Lancet 1992; 340: 1410.
Oliver N, Babu M, Diegelmann R . Fibronectin gene transcription is enhanced in abnormal wound healing. J Invest Dermatol 1992; 99: 579–86.
Babu M, Diegelmann R, Oliver N . Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989; 9: 1642–50.
Shetlar MR, Shetlar CL, Kischer CW, Pindur J . Implants of keloid and hypertrophic scars into the athymic nude mouse: changes in the glycosaminoglycans of the implants. Connect Tissue Res 1991; 26: 23–6.
Garg HG, Lippay EW, Burd DA, Neame PJ . Purification and characterisation of iduronic acid-rich and glucuronic acid-rich proteoglycans implicated in human post-burn keloid scar. Carbohydrate Res 1990; 207: 295–305.
Messadi DV, Bertolami CN . CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am J Pathol 1993; 142: 1041–9.
DiCesare PE, Cheung DT, Perelman N, Libaw E, Peng L, Nimni ME . Alteration of collagen composition and cross-linking in keloid tissues. Matrix 1990; 10: 172–8.
Low SQ, Moy RL . Scar wars strategies: target collagen. J Dermatol Surg Oncol 1992; 18: 981–6.
Tan EM, Rouda S, Greenbaum SS, Moore JH Jr, Fox JW, Sollberg S . Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am J Pathol 1993; 142: 463–70.
McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC . Altered cytokine production in black patients with keloids. J Clin Immunol 1992; 12: 300–8.
Dustan HP . Growth factors and racial differences in severity of hypertension and renal diseases. Lancet 1992; 339: 1339–40.
Tan EM, Peltonen J . Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts. Biochem J 1991; 278: 863–9.
Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J . Activation of collagen gene expression in keloids: colocalisation of type I and VI collagen and transforming growth factor-betal mRNA. J Invest Dermatol 1991; 97: 240–8.
Castagnoli C, Stella M, Berthod C, Magliacani G, Richiardi PM . TNF production and hypertrophic scarring. Cell Immunol 1993; 147: 51–63.
Shah M, Foreman DM, Ferguson MWJ . Control of scarring in adult wounds by neutralising antibody to transforming growth factor ß. Lancet 1993; 339: 213–4.
Granstein RD, Flotte IJ, Amento EP . Interferons and collagen production. J Invest Dermatol 1990; 95 (Suppl 6): 758–808.
Larrabee WF Jr, East CA, Jaffe HS, Stephenson C, Peterson KE . Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159–62.
Hambleton J, Shakespeare PG, Pratt BJ . The progress of hypertrophic scars monitored by ultrasound measurements of thickness. Burns 1992; 18: 301–7.
Ehrlich HP, Kelley SF . Hypertrophic scar: an interruption in the remodeling of repair: a laser Doppler blood flow study. Plastic Reconstructive Surg 1992; 90: 993–8.
Sproat JE, Dalcin A, Weitauer N, Roberts RS . Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment. Plastic Reconstructive Surg 1992; 90: 988–92.
Sawada Y, Sone K . Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plastic Surg 1992; 45: 599–603.
Lee RC, Ping JA . Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res 1990; 49: 463–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGrouther, D. Hypertrophic or keloid scars?. Eye 8, 200–203 (1994). https://doi.org/10.1038/eye.1994.46
Issue Date:
DOI: https://doi.org/10.1038/eye.1994.46
This article is cited by
-
Keloid scarring: bench and bedside
Archives of Dermatological Research (2009)